Literature DB >> 25747550

Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents.

Sanjay R Patel1, Rahul Gangwal2, Abhay T Sangamwar2, Rahul Jain3.   

Abstract

The synthesis and anti-tuberculosis activity for three series of 2,4-disubstituted quinolines is reported. The synthesized compounds were evaluated for activity against M. tuberculosis H37Rv strain; most promising compounds from the series exhibited MIC99 values ranged between 3.125 and 6.25 μg/mL. None of the compounds exhibited cytotoxicity up to the highest test concentration of 200 μg/mL. To understand the relationship between structure and activity, a 3D-QSAR analysis has been carried out by Comparative Molecular Field Analysis (CoMFA). Atom-fit alignment provided the best model, and allowed prediction of the activity of molecules in the test sets leading to the rationalization of the relationship between structure and activity.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Homolytic free radical reaction; Ring-substituted quinolines; Synthesis; Tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 25747550     DOI: 10.1016/j.ejmech.2015.02.034

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.

Authors:  Sara Guariento; Olga Bruno; Paola Fossa; Elena Cichero
Journal:  Mol Divers       Date:  2015-08-20       Impact factor: 2.943

2.  Quinolines derivatives as promising new antifungal candidates for the treatment of candidiasis and dermatophytosis.

Authors:  Gabriella da Rosa Monte Machado; Denise Diedrich; Thaís Carine Ruaro; Aline Rigon Zimmer; Mário Lettieri Teixeira; Luís Flávio de Oliveira; Mickael Jean; Pierre Van de Weghe; Saulo Fernandes de Andrade; Simone Cristina Baggio Gnoatto; Alexandre Meneghello Fuentefria
Journal:  Braz J Microbiol       Date:  2020-07-31       Impact factor: 2.476

3.  Analysis of Approaches to Anti-tuberculosis Compounds.

Authors:  Sara Motamen; Ronald J Quinn
Journal:  ACS Omega       Date:  2020-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.